Literature DB >> 18035555

The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons.

Francesco Errico1, Emanuela Santini, Sara Migliarini, Anders Borgkvist, Diego Centonze, Valentina Nasti, Manolo Carta, Valentina De Chiara, Chiara Prosperetti, Daniela Spano, Denis Herve, Massimo Pasqualetti, Roberto Di Lauro, Gilberto Fisone, Alessandro Usiello.   

Abstract

Rhes is a small GTP-binding protein prominently localized in the striatum. Previous findings obtained in cell culture systems demonstrated an involvement of Rhes in cAMP/PKA signalling pathway, at a level proximal to the activation of heterotrimeric G-protein complex. However, its role in the striatum has been, so far, only supposed. Here we studied the involvement of Rhes in dopaminergic signalling, by employing mice with a null mutation in the Rhes gene. We demonstrated that the absence of Rhes modulates cAMP/PKA signalling in both striatopallidal and striatonigral projection neurons by increasing Golf protein levels and, in turn, influencing motor responses challenged by dopaminergic agonist/antagonist. Interestingly, we also show that Rhes is required for a correct dopamine-mediated GTP binding, a function mainly associated to stimulation of dopamine D2 receptors. Altogether, our results indicate that Rhes is an important modulator of dopaminergic transmission in the striatum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035555     DOI: 10.1016/j.mcn.2007.10.007

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  37 in total

1.  Striatum specific protein, Rhes regulates AKT pathway.

Authors:  Sookhee Bang; Catherine Steenstra; Sangwon F Kim
Journal:  Neurosci Lett       Date:  2012-06-06       Impact factor: 3.046

2.  Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Authors:  Francesco Napolitano; Alessandra Bonito-Oliva; Mauro Federici; Manolo Carta; Francesco Errico; Salvatore Magara; Giuseppina Martella; Robert Nisticò; Diego Centonze; Antonio Pisani; Howard H Gu; Nicola B Mercuri; Alessandro Usiello
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

3.  PKA modulates iron trafficking in the striatum via small GTPase, Rhes.

Authors:  Bo-Ran Choi; Sookhee Bang; Yong Chen; Jaime H Cheah; Sangwon F Kim
Journal:  Neuroscience       Date:  2013-08-30       Impact factor: 3.590

4.  Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum.

Authors:  Valentina De Chiara; Francesco Errico; Alessandra Musella; Silvia Rossi; Giorgia Mataluni; Lucia Sacchetti; Alberto Siracusano; Maura Castelli; Francesca Cavasinni; Giorgio Bernardi; Alessandro Usiello; Diego Centonze
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

5.  Detection, validation, and downstream analysis of allelic variation in gene expression.

Authors:  Daniel C Ciobanu; Lu Lu; Khyobeni Mozhui; Xusheng Wang; Manjunatha Jagalur; John A Morris; William L Taylor; Klaus Dietz; Perikles Simon; Robert W Williams
Journal:  Genetics       Date:  2009-11-02       Impact factor: 4.562

6.  Rhes and AGS1/Dexras1 affect signaling by dopamine D1 receptors through adenylyl cyclase.

Authors:  Laura M Harrison; Youe He
Journal:  J Neurosci Res       Date:  2011-03-03       Impact factor: 4.164

7.  Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.

Authors:  Srinivasa Subramaniam; Robert G Mealer; Katherine M Sixt; Roxanne K Barrow; Alessandro Usiello; Solomon H Snyder
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

8.  Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum.

Authors:  L M Harrison; S H Muller; D Spano
Journal:  Neuroscience       Date:  2013-02-01       Impact factor: 3.590

9.  Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.

Authors:  Robert G Mealer; Srinivasa Subramaniam; Solomon H Snyder
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

10.  Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice.

Authors:  Daniela Vitucci; Annabella Di Giorgio; Francesco Napolitano; Barbara Pelosi; Giuseppe Blasi; Francesco Errico; Maria Teresa Attrotto; Barbara Gelao; Leonardo Fazio; Paolo Taurisano; Anna Di Maio; Valentina Marsili; Massimo Pasqualetti; Alessandro Bertolino; Alessandro Usiello
Journal:  Neuropsychopharmacology       Date:  2015-07-31       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.